Pharmaceutical patent litigation is becoming increasingly difficult to settle, because government approval of settlements between the litigants is increasingly difficult to obtain. Assuming that litigants want to settle, what are the terms and the process for getting government approval, especially FTC approval? A former General Counsel of the FTC, now representing pioneering pharmaceutical companies, offers practical insights on how to navigate this very challenging process.
Stay Up To Date with Ropes & Gray
Subscribe to Our Podcast
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Follow Us on Social
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
Join Our Mailing List
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.